Galera Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
GRTX Nasdaq 8731 https://www.galeratx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Galera Therapeutics Inc

Galera Announces Presentation of Supplemental Analysis of Phase 3 ROMAN Trial at European Congress on Head and Neck Oncology - Mar 10th, 2023 12:00 pm
These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts - Mar 8th, 2023 2:53 pm
Galera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates - Mar 8th, 2023 12:00 pm
Galera Therapeutics expects to raise $30M from direct stock offering - Feb 15th, 2023 5:43 pm
Galera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants - Feb 15th, 2023 1:45 pm
Galera Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis - Feb 15th, 2023 1:00 pm
Companies Like Galera Therapeutics (NASDAQ:GRTX) Could Be Quite Risky - Feb 5th, 2023 12:35 pm
Malvern-based Galera shares rise on FDA filing for lead cancer therapy drug - Dec 12th, 2022 4:37 pm
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis - Dec 12th, 2022 12:00 pm
Galera to Present at Piper Sandler Annual Healthcare Conference - Nov 22nd, 2022 12:00 pm
Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates - Nov 9th, 2022 12:00 pm
One Galera Therapeutics, Inc. (NASDAQ:GRTX) insider upped their stake by 50% in the previous year - Nov 7th, 2022 3:08 pm
Galera Therapeutics' Avasopasem Reduces Chemo-Related Kidney Disease By 50% Versus Placebo At One-Year - Oct 26th, 2022 7:16 pm
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting - Oct 26th, 2022 5:40 pm
Galera to Present at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting - Sep 26th, 2022 11:00 am
Galera to Participate in the H.C. Wainwright 24th Annual Global Investment Conference - Sep 6th, 2022 11:00 am
Galera Appoints Eugene P. Kennedy, M.D., F.A.C.S., as Chief Medical Officer - Sep 1st, 2022 11:00 am
Here's Why Galera Therapeutics (NASDAQ:GRTX) Must Use Its Cash Wisely - Aug 29th, 2022 10:47 am
Galera Reports Second Quarter 2022 Financial Results and Recent Corporate Updates - Aug 9th, 2022 11:00 am
Galera Therapeutics' Rucosopasem Shows Early Anti-Cancer Activity, Pulmonary Function Preservation - Jun 29th, 2022 4:05 pm